A detailed history of Invesco Ltd. transactions in Absci Corp stock. As of the latest transaction made, Invesco Ltd. holds 37,900 shares of ABSI stock, worth $156,906. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,900
Holding current value
$156,906
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.92 - $6.58 $110,668 - $249,382
37,900 New
37,900 $116,000
Q1 2023

May 12, 2023

SELL
$1.58 - $3.41 $1,940 - $4,187
-1,228 Reduced 6.92%
16,516 $28,000
Q4 2022

Feb 13, 2023

SELL
$2.0 - $3.58 $306 - $547
-153 Reduced 0.85%
17,744 $37,000
Q3 2022

Nov 14, 2022

SELL
$2.95 - $4.83 $295 - $483
-100 Reduced 0.56%
17,897 $56,000
Q2 2022

Aug 15, 2022

BUY
$3.13 - $8.83 $20,460 - $57,721
6,537 Added 57.04%
17,997 $60,000
Q1 2022

May 16, 2022

BUY
$5.87 - $9.46 $67,270 - $108,411
11,460 New
11,460 $96,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $384M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.